FDA Medical Device Consulting: Turning Compliance Burden into Market Authorizations
From breakthrough technologies to traditional devices, our expert FDA regulatory consultants navigate evolving FDA expectations, transforming regulatory milestones into commercial acceleration points.
Why Top Innovators Trust Our FDA Regulatory Consultants’ Medical Device Expertise
Decades of direct collaboration with FDA reviewers gives our regulatory consultants medical device insights that transcend written guidance. We anticipate reviewer questions before they're asked, identify submission pitfalls before they emerge, and design strategies that align with both agency priorities and your commercialization timeline. Our specialists maintain ongoing dialogue with FDA leadership, regularly attend industry forums, and leverage this intelligence to craft the right regulatory approach for each stage of your company's growth—whether you're launching your first device or expanding a mature portfolio.
Headline
1500+
Total Number of FDA Submissions and Amendments Worked

Headline
20+ Disciplines
Deep expertise across 20+ different regulatory disciplines

Headline
Broad device type expertise
Software (SaMD), Active Implantable (AIMD), In Vitro Diagnostics (IVDs), Combination Products, Drug-delivery, Surgical Instruments, Durable Medical Equipment (DME), Radiological Devices, etc.

What Clients Say
"Veranex gave us confidence that the extra steps were worth it. Their expertise gave us guardrails and then they empowered us to make the right business decisions, which was invaluable."
By David Goodman, VP of Marketing at Provisio
What Clients Say
"This is terrific. First of all, I am so impressed with how quickly you turned this around. This has been a big question that our team has been grappling with for a while so this is amazing to see this come together so quickly and give us a very thorough and thoughtful response."
By Jennifer Fried, CEO at Flow Medical
FDA Compliance and Beyond: Architecting Your Medical Device's
Our FDA medical device consulting delivers pathway-optimized regulatory strategies, balancing speed with robust compliance. We conduct a comprehensive assessment of your technology, indications for use, intended use, and strategic commercial goals, then define the optimal regulatory plan for traditional, breakthrough, or De Novo pathways.
Our expert FDA regulatory consultants proactively engage the agency via strategic Q-Submissions, establishing productive dialogue prior to formal submissions. We understand that successful FDA navigation demands more than technical compliance; it requires strategic positioning. This includes crafting compelling benefit-risk narratives that resonate with reviewers and directly build the foundation for your device's commercial success.
Laying the right foundation is crucial. We architect your optimal regulatory approach with precision and strategic insight:
- Comprehensive US Regulatory Strategy development
- Strategic Q-Submission planning and execution (Informational Meetings, Pre-Submissions, Submission Issue Requests, Study Risk Determinations, etc.)
- Regulatory pathway analysis (510(k), De Novo, PMA) with data requirement mapping
- Breakthrough Device Designation (BDD) and Safer Technologies Program (STeP) application development
- Regulatory landscape assessment and submission timing optimization to align with business milestones
- Predicate device identification and Substantial Equivalence (SE) strategy development
- FDA meeting preparation with mock Q&A sessions
Our FDA medical device consulting teams craft submissions designed to be clear, concise, and easy for FDA reviewers to navigate:
- Comprehensive Premarket Notification (510(k)) preparation and submission management
- De Novo submission development with benefit-risk framework optimization
- Pre-Market Approval (PMA) application preparation and traditional or modular submission planning
- Investigational Device Exemption (IDE) development with study design justification
- Emergency Use Authorization (EUA) request development and expedited review management
- Humanitarian Use Device (HUD)/Humanitarian Device Exemption (HDE) application preparation
- Interactive review response strategy and documentation
- Submission deficiency remediation with rapid-response protocols
We design evidence generation approaches that satisfy both regulatory and commercial needs:
- Clinical study strategic planning aligned with FDA expectations
- Non-clinical testing program development and gap assessment
- Real-world evidence (RWE) strategy development and implementation
- FDA pre-submission meeting strategy for study design validation
- Substantial Equivalence (SE) testing strategy optimization
- Benefit-risk assessment framework development
- FDA guidance-aligned performance testing protocols
- Human factors and usability testing program development
- Special controls compliance strategy for novel devices
Our FDA medical device consulting extends beyond clearance or approval to support your entire product lifecycle:
- Strategic labeling development and claim optimization
- Post-approval study design and implementation
- Field action and recall advisory support with FDA communication management
- Annual reporting strategy and preparation
- Change assessment and implementation planning
- Post-market surveillance program development
- FDA inspection preparation and remediation support
- Supplemental submission strategy and development
- Regulatory intelligence monitoring for FDA policy shifts
Related Articles
Latest Blog Entries
Meet the Team
Meet Our FDA Medical Device Consulting Experts
Valerie Defiesta-Ng
Sr Director, Regulatory Affairs
Valerie Defiesta-Ng is our Executive Director of Regulatory Affairs. Valerie brings 25+ years of regulatory affairs experience at both small and large medical device companies. Her professional background includes regulatory affairs, regulatory compliance, clinical research, and product development. Valerie has obtained numerous regulatory clearances and approvals from FDA and has actively participated in multiple FDA and State of California FDB inspections. She has secured the CE Mark and international registrations for a myriad of products and participated in numerous successful Notified Body audits. Additionally, Valerie has written protocols for clinical trials in support of PMA submissions and she has been involved in U.S. and international clinical studies. In her regulatory capacity, Valerie has worked closely with company Marketing and Business Development teams to ensure that product labeling and marketing materials are compliant to relevant standards. At Veranex, Valerie manages clients’ regulatory requirements for product development, manufacturing, clinical trials, submissions, commercialization activities and post-market compliance. Valerie is responsible for formal and informal communications with FDA as well as international regulatory agencies.
Gowan Lee
Sr Director, Regulatory Affairs
Gowan Lee is our Senior Director of Regulatory Affairs and Quality. Gowan is an experienced medical device professional with over 28 years of experience in Regulatory Affairs, Quality, and Clinical Affairs at global medical device companies. Gowan has held global leadership roles in Regulatory and Quality at Medtronic and Zimmer Biomet with broad experience supporting design and development projects in manufacturing site business units in the United States and Europe as well as regional, commercial activities in Asia Pacific. She has also led RA/QA organizations in corporate, regional, and country roles. Additionally, she held global leadership role in Corporate Regulatory Affairs and Quality to develop and execute strategies for inorganic and organic growth opportunities (Mergers & Acquisitions and Strategic Alliance Partnerships).
Naghmeh Nouri
Executive Director, Quality Engineering
As Executive Director of Quality and Regulatory in a strategic consulting role, Naghmeh Nouri brings more than 30 years of sophisticated blend of regulatory acumen and business insight across the global medical device landscape including emerging technologies in cardiovascular devices, digital health, AI-driven solutions and various therapeutic medical devices. She partners with executive teams to translate complex regulatory requirements into integrated strategies that align with product development and commercialization goals. With a proven track record in design assurance, verification and validation, risk management, regulatory submissions, CE marking, QMS implementation, and post-market compliance, she also bring particular strength in process validation, outsourced manufacturing oversight, and collaboration with contract manufacturing organizations (CMOs). Her ability to balance strategic vision with operational execution enables organizations to accelerate market access while maintaining the highest standards of quality and regulatory integrity and empower clients to scale with confidence.
Case Studies
FDA Medical Device Consulting Success Stories with Veranex
Provisio Medical's FDA Clearance
Situation
Provisio Medical was developing a novel IVUS (Intravascular Ultrasound) device, the Provisio™ SLT IVUS™ System, which uses A-mode ultrasound to provide real-time dimensional measurements of the vessel lumen. This device was unique because it integrated into a support crossing catheter and provided numerical data instead of traditional grayscale images.
The main challenge was proving the accuracy of the device's measurements to the FDA, as physicians were accustomed to interpreting images. The FDA challenged Provisio during a Pre-Submission meeting to scientifically demonstrate the validity of their measurements.
Successes
- Successfully demonstrated the accuracy of the device's measurements to the FDA by developing a sophisticated cadaver model that showed equivalence to traditional IVUS technology without needing human clinical trials.
- Obtained FDA clearance for the Provisio™ SLT IVUS™ System.
Services by Veranex
Veranex partnered with Provisio to obtain FDA clearance. Our teams provided cross-functional expertise in the following areas:- Regulatory strategy and consulting
- Preclinical studies
- Usability studies
- Quality assurance and engineering
510(k) Certification of a Laparoscopic Retrieval Bag
Situation
A client had spent three years developing multiple sizes of a novel laparoscopic specimen retrieval bag. They partnered with Veranex’s product design team to finalize the device design and initially planned to submit all sizes together through a Traditional 510(k). However, when some testing results were delayed, they turned to Veranex’s regulatory team to identify an expedited pathway to market.
Successes
Veranex's regulatory experts quickly devised a phased strategy, recommending a Traditional 510(k) for the primary bag size with complete testing, while positioning additional sizes for subsequent Special 510(k) submission. Our team collaborated closely with the client to draft and file the 510(k), which passed FDA's Refuse to Accept (RTA) review without issues. The submission was cleared in well under 90 days with only one Additional Information request and no interactive review questions or comments — a notably efficient process.
Services by Veranex
- Regulatory strategy development, including expedited pathway identification
- Full 510(k) submission preparation and FDA submission management
- Risk assessment and documentation support
- Human factors engineering guidance
- Sterilization and packaging validation consulting
Discover More
Related Services at Veranex
Quality Consulting
Ensure your regulatory submissions are backed by robust quality processes that satisfy both FDA requirements and international standards —perfectly complementing your FDA medical device consulting strategy with comprehensive quality systems expertise.

Product Development and Engineering
Successfully complete the required FDA deliverables with an experienced team to navigate the complexities with effective execution.

Clinical Research Services
Seamlessly integrate your regulatory strategy with clinical execution through our specialized Medical Device CRO services. Ensuring your FDA submission path is supported by strategically designed studies that meet submission requirements and your commercial objectives.

MDR Consulting
Expand beyond FDA compliance with our MDR consulting services, creating a harmonized regulatory approach that aligns your FDA medical device strategy with European requirements for seamless global market access.

Connect With Our FDA Medical Device Consulting Experts Today
Whether you're seeking your first clearance or managing a complex portfolio, our team delivers pathway-optimized strategies that accelerate your time to market while ensuring compliance.



